Evaluation the effect of Crocus sativus extract on prevention of nephropathy induced by coronary angiograpy

Evaluation the effect of Crocus sativus extract on prevention of nephropathy induced by coronary angiograpy : A triple blind randomized placebo controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170112031893N6

Enrollment

120

Registered

2020-01-06

Start date

2019-12-22

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contract induced nephropathy. Nephropathy induced by other drugs, medicaments and biological substances

Interventions

Intervention 1: Intervention group: Treatment group with saffron extract capsule (containing 1 gram) for 5 days before angiography. Intervention 2: Control group: Placebo group with starch capsule (co

Eligibility

Sex/Gender

All

Age

12 Years to 90 Years

Inclusion criteria

Inclusion criteria: patients undergo elective coronary angiography

Exclusion criteria

Exclusion criteria: pre-existing end-stage renal disease requiring dialysis cardiogenic shock serum creatinine level above 5 mg/dl

Design outcomes

Primary

Measure	Time frame
Serum creatinin. Timepoint: 3 Day before angiograohy and 3 day after angiography. Method of measurement: blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Fakhreddin Hejazi

Ghoum University of Medical Sciences

Huqom1394@yahoo.com009832854011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026